Registry update — unassessed
METforMIN: Metformin Administration for the Minimization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration
Trial registry update: COMPLETED. Results are posted in the registry; assessment pending.
RCTNotable significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Jun 9, 2023 · Discovered: Sep 15, 2026 · Assessed: — · Historical research backfill
What it does not prove
- This abstract provides no results—it is only a statement of purpose, so no effectiveness or safety conclusions can be drawn
- No information is given on study duration, follow-up period, or outcome measures, preventing assessment of what was actually measured
- The RCT design is stated but critical details (sample size, participant allocation, outcomes achieved) are absent, so the study's actual conduct and findings remain unknown
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- Non-diabetic patients with Age-related Macular Degeneration (AMD)
- Primary outcome
- Safe and effective treatment to decrease the progression of geographic atrophy in non-diabetic patients with Age-related Macular Degeneration
- Effect size
- —
- Significance
- Not reported
- Journal
- University of California, San Francisco
- Published
- Jun 9, 2023
Sources
Primary source
- University of California, San Francisco ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
The purpose of this study is to determine whether metformin, an FDA-approved drug for the treatment of type II diabetes, is a safe and effective treatment to decrease the progression of geographic atrophy in non-diabetic patients with Age-related Macular Degeneration (AMD).
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.